Kweichow Moutai
600519
Cambricon
688256
BYD Company Limited
002594
4
Hand Enterprise Solutions
300170
5
China Vanke Co.,Ltd.
000002
CN Stock MarketDetailed Quotes
002793 Luoxin Pharmaceuticals Group Stock
- 3.64
- -0.05-1.36%
Market Closed Jan 24 15:00 CST
3.96BMarket Cap-5.68P/E (TTM)
3.70High3.61Low114.90KlotVolume3.69Open3.69Pre Close41.81MTurnover1.06%Turnover RatioLossP/E (Static)1.09BShares5.8052wk High1.88P/B3.95BFloat Cap3.2252wk Low4.06Limit Up1.09BShs Float27.94Historical High3.32Limit Down2.44%Amplitude3.22Historical Low--Dividend TTM3.64Avg Price73.31KlotAsk--Div YieldTTM100Lot Size39.91KlotBid
Luoxin Pharmaceuticals Group Stock News
Luo Xin Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement of Resolutions of the 22nd Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Announcement on providing guarantees for holding subsidiaries
Luoxin Pharmaceutical: Announcement on providing guarantees for holding subsidiaries
Luoxin Pharmaceutical: Announcement of Resolutions of the 21st Meeting of the Fifth Board of Directors
Luo Xin Pharmaceutical: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement on Abnormal Fluctuations in Stock Trading
Luoxin Pharmaceutical: Progress Announcement on Providing Guarantees for Holding Subsidiaries
Luoxin Pharmaceutical: Announcement on providing guarantee amounts for holding subsidiaries
Luo Xin Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement of Resolutions of the 20th Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Announcement on changing the signed certified public accountant
Roxin Pharmaceutical: Announcement on obtaining a drug registration certificate for rabeprazole sodium enteric tablets
Luoxin Pharmaceutical: Announcement of Resolutions of the 16th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement of Resolutions of the 19th Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Fifth Board of Directors
Luoxin Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors
Luoxin Pharmaceutical: Announcement on providing guarantees for holding subsidiaries to carry out financial leasing business
Luoxin Pharmaceutical: Announcement on obtaining a drug registration certificate for the new indications of tigoracin tablets
Luoxin Pharmaceutical: Legal Opinion of the Shanghai Branch of Beijing King & Wood Mallesons on the 2024 Employee Stock Ownership Plan (Draft) of Luoxin Pharmaceutical Group Co., Ltd.